Gland Pharma, Glenmark Pharma, Dabur; Buzzing Stocks Of The Day | Bazaar Open Exchange | CNBC-TV18

Gland Pharma, Glenmark Pharma, Dabur; Buzzing Stocks Of The Day | Bazaar Open Exchange | CNBC-TV18

Sun Pharma, Gland Pharma, Zomato Are Key Stocks In Focus | Bazaar Open Exchange | CNBC-TV18Подробнее

Sun Pharma, Gland Pharma, Zomato Are Key Stocks In Focus | Bazaar Open Exchange | CNBC-TV18

See New Sector Rotations In The Market: Stallion Asset | CNBC TV18Подробнее

See New Sector Rotations In The Market: Stallion Asset | CNBC TV18

Glenmark Pharma Q1FY25: Co Posts Double-Digit Growth In India & Europe, Margin Improves | CNBC TV18Подробнее

Glenmark Pharma Q1FY25: Co Posts Double-Digit Growth In India & Europe, Margin Improves | CNBC TV18

JB Chemicals Acquires Razel From Glenmark Pharma: Nikhil Chopra Exclusive | Bazaar Open ExchangeПодробнее

JB Chemicals Acquires Razel From Glenmark Pharma: Nikhil Chopra Exclusive | Bazaar Open Exchange

Gland Pharma Slips Over 14%, Glenmark, Lupin Receive U.S FDA Observation | Markets Today | CNBC-TV18Подробнее

Gland Pharma Slips Over 14%, Glenmark, Lupin Receive U.S FDA Observation | Markets Today | CNBC-TV18

Decoding Concerns Revolving Around Gland Pharma & Its Performance | NSE Closing Bell | CNBC-TV18Подробнее

Decoding Concerns Revolving Around Gland Pharma & Its Performance | NSE Closing Bell | CNBC-TV18

Market In October Series: Gland Pharma Q2 Disappoints; Metal Stocks Shine In Trade & Much MoreПодробнее

Market In October Series: Gland Pharma Q2 Disappoints; Metal Stocks Shine In Trade & Much More

Q4FY24 Results: CLSA Downgrades Sun Pharma To Underperform; Nomura Neutral On Gland PharmaПодробнее

Q4FY24 Results: CLSA Downgrades Sun Pharma To Underperform; Nomura Neutral On Gland Pharma

Deepak Shenoy Shares His Views On Gland Pharma's Acquisition | NSE Closing Bell | CNBC-TV18Подробнее

Deepak Shenoy Shares His Views On Gland Pharma's Acquisition | NSE Closing Bell | CNBC-TV18

Bazaar: The Most Comprehensive Show On Stock Markets | Full Show | September 20, 2024 | CNBC TV18Подробнее

Bazaar: The Most Comprehensive Show On Stock Markets | Full Show | September 20, 2024 | CNBC TV18

Top Stocks To Watch Out For In Today's Trading Session | Bazaar Morning Call | CNBC-TV18Подробнее

Top Stocks To Watch Out For In Today's Trading Session | Bazaar Morning Call | CNBC-TV18

Understanding Brokerage Reports On Lupin And Gland Pharma | Halftime Report | CNBC-TV18Подробнее

Understanding Brokerage Reports On Lupin And Gland Pharma | Halftime Report | CNBC-TV18

Q2FY23 Results: PCBL & Gland Pharma Stocks Under Pressure Post Results | Chartbusters | CNBC-TV18Подробнее

Q2FY23 Results: PCBL & Gland Pharma Stocks Under Pressure Post Results | Chartbusters | CNBC-TV18

Q4FY23: Gland Pharma, Glenmark Pharma Under Pressure While Divi's Lab Surges In Trade | CNBC TV18Подробнее

Q4FY23: Gland Pharma, Glenmark Pharma Under Pressure While Divi's Lab Surges In Trade | CNBC TV18

Decoding Gland Pharma's Q2FY23 Results As The Stock Is Down Almost 15% | Halftime Report | CNBC-TV18Подробнее

Decoding Gland Pharma's Q2FY23 Results As The Stock Is Down Almost 15% | Halftime Report | CNBC-TV18

Buzzing Stocks Of The Day- 10th Sept | Axis Bank, Reliance, Glenmark & Sun Pharma| ChartbustersПодробнее

Buzzing Stocks Of The Day- 10th Sept | Axis Bank, Reliance, Glenmark & Sun Pharma| Chartbusters

Gland Pharma Reports Weak Q1FY25, Revenue Down 16%, Margin Lowest Since Q4FY23 | CNBC TV18Подробнее

Gland Pharma Reports Weak Q1FY25, Revenue Down 16%, Margin Lowest Since Q4FY23 | CNBC TV18

Midcap Spotlight: Ekta Batra Decodes Glenmark Pharma Surges In Trade | Midcap Radar | CNBC-TV18Подробнее

Midcap Spotlight: Ekta Batra Decodes Glenmark Pharma Surges In Trade | Midcap Radar | CNBC-TV18

Bino Pathiparampil Shares Views On Gland Pharma's Q2FY23 Results | Halftime Report | CNBC-TV18Подробнее

Bino Pathiparampil Shares Views On Gland Pharma's Q2FY23 Results | Halftime Report | CNBC-TV18